Changes in the quality of life of advanced melanoma patients after 12 weeks of treatment with ipilimumab compared to gp100 in a Phase III clinical trial

Authors:

Harvey B, Lee D, Gaudin A-F, Gueron B, Bregman B, Lebbé C and Borget I.

Publication Type:

Conference Proceedings – Poster

Publication Name:

American Society of Clinical Oncology (ASCO) Annual Meeting

Citation:

Harvey B, Lee D, Gaudin A-F, Gueron B, Bregman B, Lebbé C and Borget I. Changes in the quality of life of advanced melanoma patients after 12 weeks of treatment with ipilimumab compared to gp100 in a Phase III clinical trial. American Society of Clinical Oncology (ASCO) Annual Meeting. Chicago, United States of America. 31 May – 4 June. Poster 50C.


Link to publication ⟶

⟵ Back to Search Results